Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

8.860
+1.00012.72%
Volume:471.71M
Turnover:3.97B
Market Cap:102.05B
PE:22.01
High:9.010
Open:7.900
Low:7.790
Close:7.860
Loading ...

CSPC Pharmaceutical Group Limited's (HKG:1093) Share Price Not Quite Adding Up

Simply Wall St.
·
10 Feb

CSPC Pharmaceutical Get China Nod for Herpes Zoster Drug Trial

MT Newswires Live
·
07 Feb

BRIEF-CSPC Pharmaceutical Says Sys6017 Obtained Clinical Trial Approval From NMPA

Reuters
·
07 Feb

CSPC Pharmaceutical - Sys6017 (Herpes Zoster Mrna Vaccine) Obtains Clinical Trial Approval From Nmpa

THOMSON REUTERS
·
07 Feb

CSPC Pharmaceutical Gets China Nod for Registration of Tumor Drug

MT Newswires Live
·
21 Jan

BRIEF-Cspc Pharmaceutical Says Regorafenib Tablets Obtains Drug Registration Approval

Reuters
·
20 Jan

CSPC Pharmaceutical - Regorafenib Tablets Obtains Drug Registration Approval From Nmpa China

THOMSON REUTERS
·
20 Jan

BRIEF-CSPC Pharmaceutical Says Sys6043 Obtains Clinical Trial Approval

Reuters
·
16 Jan

CSPC Pharmaceutical Gets FDA Approval for Clinical Trial of Tumor Drug in US

MT Newswires Live
·
16 Jan

CSPC Pharmaceutical - Sys6043 (Antibody-Drug Conjugate) Obtains Clinical Trial Approval in U.S.

THOMSON REUTERS
·
16 Jan

CSPC Pharmaceutical Gets Marketing Nod for Glycemic Control Drug in China

MT Newswires Live
·
13 Jan

CSPC Pharmaceutical - Prusogliptin Tablets Obtains Marketing Approval Granted by Nmpa

THOMSON REUTERS
·
13 Jan

Earnings growth of 1.5% over 5 years hasn't been enough to translate into positive returns for CSPC Pharmaceutical Group (HKG:1093) shareholders

Simply Wall St.
·
11 Jan

CSPC Pharmaceutical Gets China Nod for Clinical Trial of Tumor Drug

MT Newswires Live
·
10 Jan

BRIEF-CSPC Pharmaceutical Says SYS6041 Obtained Clinical Trial Approval

Reuters
·
10 Jan

CSPC Pharmaceutical - Sys6041 Obtains Clinical Trial Approval

THOMSON REUTERS
·
10 Jan

CSPC Pharmaceutical Gets China Nod for Clinical Trial of Tumor Drug

MT Newswires Live
·
07 Jan

BRIEF-CSPC Pharmaceutical Says SYH2059 Tablets Obtains Clinical Trial Approval From NMPA

Reuters
·
07 Jan

BRIEF-CSPC Pharmaceutical Says SYS6045 Obtains Clinical Trial Approval From NMPA

Reuters
·
07 Jan

CSPC Pharmaceutical - Approval Granted by National Medical Products Administration

THOMSON REUTERS
·
07 Jan